To Give or Not to Give: Consolidative Durvalumab in EGFR-Mutant NSCLC. Bauman J, Borghaei H. J Thorac Oncol 2021;16:894-896.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bauman J, Borghaei H. To Give or Not to Give: Consolidative Durvalumab in EGFR-Mutant NSCLC. J Thorac Oncol 2021;16:894-896.
PMID: 34034885